Exosome Diagnostics Raises $20M | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Exosome Diagnostics has raised $20 million to further develop and commercialize its exosome-based diagnostics.

The company also said it is creating R&D and service operations in New York, where the company is based, and in Munich.

The financing round was led be NGN Capital and Forbion Capital Partners.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Being born premature shouldn't mean infants with high blood sugar levels don't undergo genetic testing for neonatal diabetes, a study in Pediatrics says.

In Cell this week: phosphoproteomic patterns in prostate cancer, effect of gene expression on fitness in yeast, and more.

Scripps Research Institute investigators peer back at the RNA world.

In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.